Skip to Content
Merck
  • Improved human tenocyte proliferation and differentiation in vitro by optimized silk degumming.

Improved human tenocyte proliferation and differentiation in vitro by optimized silk degumming.

Biomedical materials (Bristol, England) (2011-05-11)
Xiao Wang, Yiwei Qiu, Andrew J Carr, James T Triffitt, Afsie Sabokbar, Zhidao Xia
ABSTRACT

Tendon disorders are common clinical conditions. Tendon tissue engineering provides a new approach for tendon repair by integrating engineered substitutes with their native counterparts. Silk is considered to be a promising candidate for tendon engineering because of its biological and mechanical properties. However, a major concern with using silk for biomedical applications is the immune responses generated by sericin, a glue-like protein that coats the silk fibres. This study improves the existing protocols for silk 'degumming' which removes sericin and enables preparation of silk that is suitable for tendon regeneration. Bombyx mori silks were treated by sequential treatments with different proteases. The efficiency of degumming was determined by measuring weight loss, picric acid and carmine staining and scanning electron microscopy. To evaluate the cellular responses after degumming, the growth and differentiation of human tenocytes on silks were examined. The results showed that sequential protease treatment effectively degummed raw silks. The sequentially degummed silks showed enhanced tenocyte proliferation and upregulated mRNA levels of tendon markers. Thick cell multilayers formed on the treated silks, with cells and collagen fibres penetrating into the spaces in individual silk filaments, resulting in a structure resembling human tendon.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Carminic acid, ≥90% (HPLC)
Supelco
Carminic acid, analytical standard